Copolymer Suppressing Protein Adsorption in Medical Devices

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing polymer materials used in medical instruments and artificial organs suffer from protein adsorption issues, leading to low reproducibility of detection sensitivity and poor purification, and materials like PMEA have low glass transition temperatures and complex production processes.

Innovation Solution

A copolymer containing specific constitutional units derived from (meth)acrylic acid esters and macromonomers, with a weight-average molecular weight of 75,000 or more, is used to suppress protein adsorption and is suitable for producing articles that come in contact with proteins, including medical instruments and artificial organs.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If PMEA is used as a coating material, then protein adsorption is suppressed, but the coating film lacks sufficient hardness and practicality

Engineering Contradiction:
Improveprotein adsorptionVSAvoidhardness
Core Design Contradiction:
Object-affected harmful factorsVSStrength

Solution Approach 1:

The patent uses a copolymer comprising both PMEA units (for protein adsorption suppression) and PMMA units (for hardness). This composite polymer structure allows simultaneous achievement of biocompatibility and mechanical strength, resolving the contradiction between softness and hardness.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent adjusts the glass transition temperature parameter by incorporating PMMA units with higher Tg than PMEA. This parameter change enables the coating film to maintain sufficient hardness and practicality while preserving the protein adsorption suppression capability through the PMEA component.

Inventive Principle:
Principle #35Parameter changes

2Object-affected harmful factors

If heat treatment and ultrapure water exposure method is used, then platelet adsorption is suppressed, but the producing process becomes complicated and time-consuming

Engineering Contradiction:
Improveplatelet adsorptionVSAvoidproducing process complexity
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The patent incorporates platelet adsorption suppression functionality directly into the polymer structure during synthesis, rather than requiring post-synthesis heat treatment and water exposure steps. This preliminary action eliminates complex processing steps while achieving the desired biological performance.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The copolymer structure itself provides the platelet adsorption suppression capability through its chemical composition, eliminating the need for external heat treatment and water exposure processes. The material serves its own function without requiring additional complex processing steps.

Inventive Principle:
Principle #25Self-service

3Reliability

If PMEA is used as a molding material, then biocompatibility is achieved, but the very low glass transition temperature makes it difficult to use

Engineering Contradiction:
ImprovebiocompatibilityVSAvoidglass transition temperature
Core Design Contradiction:
ReliabilityVSTemperature

Solution Approach 1:

The patent creates a copolymer combining PMEA (for biocompatibility) with PMMA (for high glass transition temperature). This composite structure maintains the low Tg characteristics needed for biocompatibility while incorporating higher Tg units to enable practical molding and processing.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent modifies the glass transition temperature parameter of the polymer system by incorporating PMMA units. This parameter adjustment enables the material to be suitable for molding processes while preserving the essential biocompatibility properties through the PMEA component.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS20250206861A1Copolymer for suppressing protein adsorption, method for producing copolymer, resin modifier, molding material, copolymer-containing composition, coating film, and article
Publication Date: 2025.06.26 MITSUBISHI CHEM CORP
  • US20250206861A1 patent drawing
  • US20250206861A1 patent drawing
  • US20250206861A1 patent drawing

AI summary

There is provided a copolymer for suppressing protein adsorption, which contains a constitutional unit (a) represented by Formula 1 and a constitutional unit (b) represented by Formula 2, and which is used for producing an article that comes in contact with a protein. In the formula, R1 represents a hydrogen atom or a methyl group, R2 represents an OR33, a halogen atom, COR34, COOR35, CN, CONR36R37, or R38, where R33 to R37 each independently represent a hydrogen atom, a substituted or unsubstituted alkyl group, a substituted or unsubstituted alicyclic group, a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group, a substituted or unsubstituted non-aromatic heterocyclic group, a substituted or unsubstituted aralkyl group, a substituted or unsubstituted alkaryl group, or a substituted or unsubstituted organosilyl group, and R38 represents a substituted or unsubstituted aryl group or a substituted or unsubstituted heteroaryl group.